第1页å‚è§é™„ä»¶(2336KB,3页)。
[摘è¦]ç›®çš„è§‚å¯Ÿä¸¹å‚æ³¨å°„液对慢性肺心病心力衰ç«çš„æ²»ç–—æ•ˆæžœï¼Œå¹¶ä¸Žå¸¸è§„æ²»ç–—çš„ç–—æ•ˆè¿›è¡Œå¯¹ç…§ã€‚æ–¹æ³•å¯¹ç…§ç»„äºˆæŠ—æ„ŸæŸ“ã€æ¢å’³ç¥›ç—°ã€æŒç»ä½Žæµé‡å¸æ°§ã€æ”¹å–„通气功能ã€åˆ©å°¿å¼ºå¿ƒã€çº æ£ç”µè§£è´¨ç´Šä¹±åŠé…¸ç¢±å¤±è¡¡ç‰å¸¸è§„æ²»ç–—ã€‚æ²»ç–—ç»„åœ¨ä¸Šè¿°æ²»ç–—çš„åŸºç¡€ä¸ŠåŠ ç”¨ä¸¹å‚æ³¨å°„æ¶²ã€‚ç”¨æ³•ä¸ºï¼šä¸¹å‚æ³¨å°„æ¶²40毫å‡åŠ å…¥5%è‘¡è„ç³–æ¶²250毫å‡ä¸é™è„‰æ»´æ³¨ï¼Œæ¯å¤©1次,14天为一疗程。14dåŽè¿›è¡Œç–—æ•ˆè§‚å¯Ÿã€‚ç»“æžœåŠ ç”¨ä¸¹å‚æ³¨å°„液的治疗组,有效率为96.3%,对照组的有效率为79.2%ã€‚ç»“è®ºå¸¸è§„æ²»ç–—åŸºç¡€ä¸Šè¾…ä»¥ä¸¹å‚æ³¨å°„液治疗肺心病åˆå¹¶å¿ƒè¡°å¯å–得较好的疗效,能有效改善心肺功能,能改善临床症状和体å¾ï¼Œè€Œä¸”å…·æœ‰ä»·æ ¼ä½Žå»‰ï¼Œæ— æ¯’å‰¯ä½œç”¨ç‰ä¼˜ç‚¹ï¼Œå€¼å¾—临床应用推广。
关键è¯ï¼šä¸¹å‚注射液肺心病心力衰ç«
[Abstract]Objective: To observe for chronic cor pulmonale injection salvia miltiorrhiza heart failure treatment effect, and with conventional treatment for control. Methods: Control group gives anti-infection, cough, continued low flow oxygen eliminating phlegm, improve ventilation function, strong heart, diuresis and acid and alkali balance is the electrolyte conventional treatment. The treatment group in the above the foundation of treatment combined with danshen injection. Usage: salvia miltiorrhiza 40 ml glucose injection by adding 5% to 250 ml of liquid intravenous injection, one a day, 14 days for one period of treatment. After 14 d clinical observation. Results: Add with salvia miltiorrhiza in treatment group and injection rate of 96.3% in the control group, the effective rate was 79.2%.Conclusion: Based on conventional treatment by salvia miltiorrhiza treatment with heart failure disease injection can acquire better curative effect, can effectively improve heart function, can improve the clinical symptoms and signs, and is inexpensive, non-toxic side effects and other advantages, clinical application promotion is worth.
key words:danshen injection cor pulmonale heart failure
ä¸å›¾åˆ†ç±»å·ï¼šR541æ–‡çŒ®æ ‡è¯†ç :Bæ–‡ç« ç¼–å·ï¼š1004-7484(2011)10-0062-03
æ…¢æ€§è‚ºæºæ€§å¿ƒè„ç—…(chronic pulmonary heart disease),简称慢性肺心病(chronic cor pulmonale),是由肺组织ã€è‚ºè¡€ç®¡æˆ–胸廓的慢性病å˜å¼•起肺组织结构和(或)åŠŸèƒ½å¼‚å¸¸ï¼Œäº§ç”Ÿè‚ºè¡€ç®¡é˜»åŠ›å¢žåŠ ã€‚è‚ºåŠ¨è„‰åŽ‹åŠ›å¢žé«˜ï¼Œä½¿å³å¿ƒå®¤æ‰©å¼ 或(å’Œ)肥厚,伴或ä¸ä¼´å³å¿ƒåŠŸèƒ½è¡°ç«çš„心è„病,并排除先天性心è„病和左心病å˜å¼•起者[1]ã€‚æ…¢æ€§è‚ºæºæ€§å¿ƒè„病是严é‡å±å®³äººæ°‘å¥åº·çš„疾病,常并å‘多è„器æŸå®³ï¼Œè€Œå¹¶å‘心衰者æ»äº¡çއæžé«˜[2]。近年æ¥ï¼Œæˆ‘院在常规治疗基础上,辅以丹å‚麦注射液治疗肺心病心衰,å–å¾—è¾ƒç†æƒ³æ•ˆæžœï¼ŒçŽ°æŠ¥é“如下:
1资料与方法
1.1 一般资料
肺心病åˆå¹¶å¿ƒè¡°æ€¥æ€§å‘作ä½é™¢æ‚£è€…118例,其ä¸ï¼Œç”·74例,女44例;年龄54~82å²ï¼Œå¹³å‡68å²ï¼›ç—…程5~38年。所有病例å‡ç¬¦åˆã€Šå†…ç§‘å¦ã€‹ç¬¬å…版ä¸è‚ºå¿ƒç—…è¯Šæ–æ ‡å‡†ã€‚éšæœºåˆ†ä¸ºæ²»ç–—组80例,对照组48例。基本情况è§è¡¨1。
表1肺心病患者分组基本情况
项目
内容人数性别年龄病程(å¹´)心力衰ç«
ç”·æ€§å¥³æ€§æœ€çŸæœ€é•¿â… 级Ⅱ级Ⅲ级
治疗组80542651-79333133631
对照组48361249-78530122511
ä¸¤ç»„æ‚£è€…å¹´é¾„ã€æ€§åˆ«ã€ç—…程åŠç—…æƒ…ç›¸ä¼¼ï¼Œå…·æœ‰å¯æ¯”性。
1.2 治疗方法
å¯¹ç…§ç»„ï¼šäºˆæŠ—æ„ŸæŸ“ã€æ¢å’³ç¥›ç—°ã€æŒç»ä½Žæµé‡å¸æ°§ã€æ”¹å–„通气功能ã€åˆ©å°¿å¼ºå¿ƒã€çº æ£ç”µè§£è´¨ç´Šä¹±åŠé…¸ç¢±å¤±è¡¡ç‰å¸¸è§„æ²»ç–—ã€‚æ²»ç–—ç»„ï¼šåœ¨ä¸Žå¯¹ç…§ç»„ç›¸åŒæ²»ç–—çš„åŸºç¡€ä¸ŠåŠ ç”¨å¤æ–¹ä¸¹å‚æ³¨å°„æ¶²å’Œç”Ÿè„‰æ³¨å°„æ¶²ã€‚ç”¨æ³•ä¸ºï¼šä¸¹å‚æ³¨å°„æ¶²40毫å‡åŠ å…¥5%è‘¡è„ç³–æ¶²250毫å‡ä¸é™è„‰æ»´æ³¨ã€‚
1.2.1疗程:æ¯å¤©ä¸€æ¬¡ï¼Œ14天为一个疗程。
1.2.2ç–—æ•ˆåˆ¤å®šæ ‡å‡†ï¼šæ˜¾æ•ˆï¼šâ‘ é—´æœ‰å’³å—½ï¼Œå’³ç™½è‰²æ³¡æ²«æ ·é»ç—°ï¼Œæ˜“咯出,两肺å¶é—»å•°éŸ³ï¼ŒXçº¿æ£€æŸ¥è‚ºéƒ¨ç‚Žç—‡å¤§éƒ¨åˆ†å¸æ”¶ï¼›â‘¡å¿ƒåŠŸèƒ½æ”¹å–„è¾¾â… çº§ï¼›â‘¢ç¥žå¿—æ¸…æ¥šï¼Œç”Ÿæ´»è‡ªç†ï¼›â‘£ç—‡çжåŠä½“å¾ã€å®žéªŒå®¤æ£€æŸ¥æ¢å¤åˆ°å‘ç—…å‰æ°´å¹³ã€‚有效:①阵咳,咯åé»è„“ç—°ï¼Œä¸æ˜“咯出,两肺闻åŠå•°éŸ³ï¼›â‘¡å¿ƒè‚ºåŠŸèƒ½æ”¹å–„è¾¾â…¡çº§ï¼›â‘¢ç¥žå¿—æ¸…æ¥šï¼Œèƒ½åœ¨åºŠä¸Šæ´»åŠ¨ã€‚æ— æ•ˆï¼šä¸Šè¿°å„é¡¹æŒ‡æ ‡æ— æ”¹å–„ï¼Œæˆ–æœ‰æ¶åŒ–。
2治疗结果
æ ¹æ®æ²»ç–—å‰è®¾å®šçš„相关治疗方法以åŠç–—æ•ˆåˆ¤å®šæ ‡å‡†ï¼Œä¸´åºŠç–—æ•ˆåŸºæœ¬æƒ…å†µè§è¡¨2。
表2临床治疗效果基本情况
显效(例)有(例)æ•ˆæ— æ•ˆ(例)显效率(%)有效率(%)æ— æ•ˆçŽ‡(%)总有效率(%)
治疗组5918373.822.53.796.3
对照组27111056.322.920.879.2
æ²»ç–—ç»„æ— æ˜Žæ˜¾å‰¯ä½œç”¨ï¼Œä»…å°‘æ•°æ‚£è€…åœ¨æ»´æ³¨è¿‡ç¨‹ä¸å‡ºçްé¢éƒ¨å‘红ã€å¤´æ˜åŠè½»å¾®å¿ƒæ…Œ ......
